Application 207635
- Type
- ANDA
- Sponsor
- CNTY LINE PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUTALBITAL AND ACETAMINOPHEN | ACETAMINOPHEN; BUTALBITAL | TABLET;ORAL | 300MG;50MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207635-001 | BUTALBITAL AND ACETAMINOPHEN | ACETAMINOPHEN; BUTALBITAL | 300MG;50MG | TABLET / ORAL | 2017-06-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A207635-001 | BUTALBITAL AND ACETAMINOPHEN | 300MG;50MG | TABLET / ORAL | AA | 2017-06-05 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A207635-001 | BUTALBITAL AND ACETAMINOPHEN | 300MG;50MG | TABLET / ORAL | AA | 2017-06-05 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A207635-001 | BUTALBITAL AND ACETAMINOPHEN | 300MG;50MG | TABLET / ORAL | 2017-06-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207635-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207635-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207635-001 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207635-001 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A207635-001 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A207635-001 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207635-001 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207635-001 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A207635-001 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A207635-001 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A207635-001 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A207635-001 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A207635-001 | AA | 1 | ea99ee380514… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207635-001 | AA | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207635-001 | AA | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A207635-001 | AA | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A207635-001 | AA | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207635-001 | AA | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A207635-001 | AA | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A207635-001 | AA | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A207635-001 | AA | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| butalbital and acetaminophen | BUTALBITAL AND ACETAMINOPHEN | Par Health | e619b656-4123-4878-b601-b0edad3c428b | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | butalbital and acetaminophen |
| BUTALBITAL AND ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | Amici Pharma, Inc. | 3280501f-928a-4112-803d-fb9771c86547 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | BUTALBITAL AND ACETAMINOPHEN |
| Butalbital And Acetaminophen | BUTALBITAL AND ACETAMINOPHEN | Larken Laboratories, Inc. | 326c83fc-afed-45ad-9c87-f47968fa1d2a | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | Butalbital And Acetaminophen |
| BUTALBITAL AND ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | Aarkish Pharmaceuticals NJ Inc. | 82fa5151-d5ee-4ad8-ba7c-a2df8a09e1a6 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | BUTALBITAL AND ACETAMINOPHEN |
| BUTALBITAL AND ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | Burel Pharmaceuticals, LLC | 0a8a6a16-b23f-45d2-b5d4-540264e74d14 | 2024-10-18 | Boxed warning, Warnings, Adverse reactions | BUTALBITAL AND ACETAMINOPHEN |
| butalbital and acetaminophen | BUTALBITAL AND ACETAMINOPHEN | Dr. Reddy's Labratories Inc. | 42d808d6-d8d4-22f5-ac2f-0f0d1d71686a | 2024-08-19 | Boxed warning, Warnings, Adverse reactions | butalbital and acetaminophen |
| BUTALBITAL and ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | QUAGEN PHARMACEUTICALS LLC | 1f0dbe62-6aea-4323-ad25-c2211f919253 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | BUTALBITAL and ACETAMINOPHEN |
| BUTALBITAL and ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | QUAGEN PHARMACEUTICALS LLC | 2eb09253-7f59-401e-afbc-70bb9600fedf | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | BUTALBITAL and ACETAMINOPHEN |
| butalbital and acetaminophen | BUTALBITAL AND ACETAMINOPHEN | Granules Pharmaceuticals Inc. | 2091c292-b77b-4ce6-8bba-436c74eee3d7 | 2023-02-14 | Boxed warning, Warnings, Adverse reactions | butalbital and acetaminophen |
| Butalbital and Acetaminophen | BUTALBITAL AND ACETAMINOPHEN TABLETS | Oceanside Pharmaceuticals | d2213ffd-18f6-45f5-9af7-690a977562c4 | 2020-04-02 | Boxed warning, Warnings, Adverse reactions | Butalbital and Acetaminophen |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-534 | butalbital and acetaminophen | butalbital and acetaminophen | Alvogen Inc. | ANDA | Current |
| 47781-534 | butalbital and acetaminophen | butalbital and acetaminophen | Alvogen Inc. | ANDA | Current |
| 47781-534 | butalbital and acetaminophen | butalbital and acetaminophen | Alvogen Inc. | ANDA | Current |
| 47781-644 | butalbital and acetaminophen | butalbital and acetaminophen | Alvogen Inc. | ANDA | Current |
| 47781-644 | butalbital and acetaminophen | butalbital and acetaminophen | Alvogen Inc. | ANDA | Current |